Eurosurv. Characteristics of SARS-CoV-2 variants of concern B.1.1.7, B.1.351 or P.1: data from seven EU/EEA countries, weeks 38/2020 to 10/2021

[tetano]

• Tjede Funk[SUP]1[/SUP] , Anastasia Pharris[SUP]1[/SUP] , Gianfranco Spiteri[SUP]1[/SUP] , Nick Bundle[SUP]1[/SUP] , Angeliki Melidou[SUP]1[/SUP] , Michael Carr[SUP]2,3[/SUP] , Gabriel Gonzalez[SUP]2,3[/SUP] , Alejandro Garcia-Leon[SUP]4[/SUP] , Fiona Crispie[SUP]5[/SUP] , Lois O?Connor[SUP]6[/SUP] , Niamh Murphy[SUP]6[/SUP] , Jo?l Mossong[SUP]7[/SUP] , Anne Vergison[SUP]7[/SUP] , Anke K. Wienecke-Baldacchino[SUP]8[/SUP] , Tamir Abdelrahman[SUP]8[/SUP] , Flavia Riccardo[SUP]9[/SUP] , Paola Stefanelli[SUP]9[/SUP] , Angela Di Martino[SUP]9[/SUP] , Antonino Bella[SUP]9[/SUP] , Alessandra Lo Presti[SUP]9[/SUP] , Pedro Casaca[SUP]10[/SUP] , Joana Moreno[SUP]10[/SUP] , V?tor Borges[SUP]11[/SUP] , Joana Isidro[SUP]11[/SUP] , Rita Ferreira[SUP]11[/SUP] , Jo?o Paulo Gomes[SUP]11[/SUP] , Liidia Dotsenko[SUP]12[/SUP] , Heleene Suija[SUP]12[/SUP] , Jevgenia Epstein[SUP]12[/SUP] , Olga Sadikova[SUP]12[/SUP] , Hanna Sepp[SUP]12[/SUP] , Niina Ikonen[SUP]13[/SUP] , Carita Savolainen-Kopra[SUP]13[/SUP] , Soile Blomqvist[SUP]13[/SUP] , Teemu M?tt?nen[SUP]13[/SUP] , Otto Helve[SUP]13[/SUP] , Joana Gomes-Dias[SUP]1[/SUP] , Cornelia Adlhoch[SUP]1[/SUP] , on behalf of COVID study groups[SUP]14 [/SUP]

We compared 19,207 cases of SARS-CoV-2 variant B.1.1.7/S gene target failure (SGTF), 436 B.1.351 and 352 P.1 to non-variant cases reported by seven European countries. COVID-19 cases with these variants had significantly higher adjusted odds ratios for hospitalisation (B.1.1.7/SGTF: 1.7, 95% confidence interval (CI): 1.0?2.9; B.1.351: 3.6, 95% CI: 2.1?6.2; P.1: 2.6, 95% CI: 1.4?4.8) and B.1.1.7/SGTF and P.1 cases also for intensive care admission (B.1.1.7/SGTF: 2.3, 95% CI: 1.4?3.5; P.1: 2.2, 95% CI: 1.7?2.8).

full article

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2021.26.16.2100348#html_fulltext